Here, There, and Everywhere: The Ubiquitous Distribution of the Immunosignaling Molecule Lysophosphatidylcholine and Its Role on Chagas Disease
Open Access
- 19 February 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 7, 62
Abstract
Chagas disease is a severe illness, which can lead to death if the patients are not promptly treated. The disease is caused by the protozoan parasite Trypanosoma cruzi, which is mostly transmitted by a triatomine insect vector. There are 8-10 million people infected with T. cruzi in the world, but the vector-borne transmission occurs only in the Americas, especially Latin America. About 30 % of chronically infected people develop cardiac diseases and up to 10 % develop digestive, neurological or mixed disorders. Lysophosphatydilcholine (LPC) is the major phospholipid component of oxidized low-density lipoproteins associated with atherosclerosis-related tissue damage. Insect-derived LPC is a powerful chemoattractant for inflammatory cells at the site of the insect bite, enhances parasite invasion, and inhibits the production of nitric oxide (NO) by T. cruzi-stimulated macrophages. The recognition of the ubiquitous presence of LPC on the vector saliva, its production by the parasite itself and its presence both on patient plasma as well as its role on diverse host x parasite interaction systems lead us to compare its distribution in nature with the title of the famous Beatles song “Here, There and Everywhere” recorded exactly 50 years ago in 1966. Here, we review the major findings pointing out the role of such molecule as an immunosignaling modulator of Chagas disease transmission. Also, we believe that future investigation of the connection of this ubiquity and the immune role of such molecule may lead in the future to novel methods to control parasite transmission, infection and pathogenesis.Keywords
This publication has 82 references indexed in Scilit:
- Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK PhosphorylationPLOS ONE, 2013
- Lysophosphatidylcholine: A Novel Modulator ofTrypanosoma cruziTransmissionJournal of Parasitology Research, 2011
- Chagas diseaseThe Lancet, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- G2A and LPC: Regulatory functions in immunityProstaglandins & Other Lipid Mediators, 2009
- Trypanosoma cruziInfection Is Enhanced by Vector Saliva through Immunosuppressant Mechanisms Mediated by LysophosphatidylcholineInfection and Immunity, 2008
- Current concepts in immunoregulation and pathology of human Chagas diseaseCurrent Opinion in Infectious Diseases, 2008
- Miltefosine Affects Lipid Metabolism in Leishmania donovani PromastigotesAntimicrobial Agents and Chemotherapy, 2007
- Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction SignalCell, 2003
- Schistosomula of Schistosoma mansoni use lysophosphatidylcholine to lyse adherent human red blood cells and immobilize red cell membrane components.Journal of Cell Biology, 1986